home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

2.590 -0.010 (-0.38%)

Official Closing Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Anavex Life Sciences Stock Shows Improved Price Strength Rating ↗

February 07, 2023

Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75.

Via Investor's Business Daily

Earnings Preview: Anavex Life Sciences ↗

February 06, 2023

Via Benzinga

3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗

January 18, 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Via The Motley Fool

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today ↗

January 10, 2023

Via Benzinga

Top Picks For 2023: Anavex Life Sciences ↗

January 06, 2023

Anavex is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system diseases, with encouraging results in Alzheimer’s, Parkinson’s, and Rett...

Via Talk Markets

Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday ↗

January 03, 2023

Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market...

Via Benzinga

Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today ↗

December 27, 2022

Via Benzinga

Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years ↗

December 08, 2022

Via Benzinga

Anavex Catapults On Alzheimer's Results — But Math Question Clouds The Data ↗

December 02, 2022

A math error could have clouded the drug's actual benefits.

Via Investor's Business Daily

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,500 Today ↗

December 02, 2022

Via Benzinga

Analyzing Anavex Life Sciences's Short Interest ↗

December 21, 2022

Anavex Life Sciences's (NASDAQ:AVXL) short percent of float has risen 17.06% since its last report. The company recently reported that it has 11.91 million shares sold short, which is 15.71% of all...

Via Benzinga

Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why ↗

December 17, 2022

The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.

Via The Motley Fool

Is Anavex Life Sciences a Buy? ↗

December 13, 2022

It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.

Via The Motley Fool

Is Anavex Life Sciences a Smart Stock to Buy Now? ↗

December 03, 2022

The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?

Via The Motley Fool

Dow Drops 100 Points; Asana Shares Plummet ↗

December 02, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.

Via Benzinga

Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

December 02, 2022

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

Anavex Life Sciences (NASDAQ: AVXL) Says Phase 2b/3 for ANAVEX2-73 Met Primary and Secondary Endpoints Reducing Cognative Decline in Patients with Early Alzheimer’s

December 02, 2022

Anavex Life Sciences Corp. (NASDAQ: AVXL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and

Via Spotlight Growth

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 02, 2022

Via Benzinga

Gold Down 1%; Samsara Shares Spike Higher ↗

December 02, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.

Via Benzinga

Why Anavex Life Sciences Stock Is Surging Today ↗

December 02, 2022

The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.

Via The Motley Fool

Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News ↗

December 02, 2022

Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment.

Via InvestorPlace

Why Is Anavex Life Sciences (AVXL) Stock Up 30% Today? ↗

December 02, 2022

Anavex Life Sciences (AVXL) stock is rocketing higher on Friday following positive results from an Alzheimer’s clinical trial.

Via InvestorPlace

Smartsheet, Samsara, Anavex Life Sciences And Some Other Big Stocks Moving Higher On Friday ↗

December 02, 2022

U.S. stocks traded mostly lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs ↗

December 02, 2022

U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 02, 2022

Via Benzinga

Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It' ↗

December 01, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Williams Companies, Inc. (NYSE: WMB) is "terrific." He recommended buying the stock.

Via Benzinga

Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

November 28, 2022

Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns.

Via Benzinga

Why Shares of Anavex Life Sciences Slumped 23.5% on Monday ↗

November 28, 2022

The company released its fourth-quarter and full-year numbers.

Via The Motley Fool

Dow Tumbles 450 Points; S&P 500 Falls 1.5% ↗

November 28, 2022

U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com